doi: 10.2147/DDDT.S398021.
eCollection 2022.
A Novel Tetrandrine-Loaded Chitosan Microsphere: Characterization and in vivo Evaluation [Retraction]
- PMID: 36425304
- PMCID: PMC9680986
- DOI: 10.2147/DDDT.S398021
Item in Clipboard
A Novel Tetrandrine-Loaded Chitosan Microsphere: Characterization and in vivo Evaluation [Retraction]
Drug Des Devel Ther.
.
Abstract
[This retracts the article DOI: 10.2147/DDDT.S103169.].
© 2022 Dove Medical Press.
Retraction of
-
A novel tetrandrine-loaded chitosan microsphere: characterization and in vivo evaluation.Drug Des Devel Ther. 2016 Mar 30;10:1291-8. doi: 10.2147/DDDT.S103169. eCollection 2016. Drug Des Devel Ther. 2016. Retraction in: Drug Des Devel Ther. 2022 Nov 18;16:4015-4016. doi: 10.2147/DDDT.S398021. PMID: 27099474 Free PMC article. Retracted.
Similar articles
-
A novel tetrandrine-loaded chitosan microsphere: characterization and in vivo evaluation.Drug Des Devel Ther. 2016 Mar 30;10:1291-8. doi: 10.2147/DDDT.S103169. eCollection 2016. Drug Des Devel Ther. 2016. Retraction in: Drug Des Devel Ther. 2022 Nov 18;16:4015-4016. doi: 10.2147/DDDT.S398021. PMID: 27099474 Free PMC article. Retracted.
-
Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery [Retraction].Drug Des Devel Ther. 2022 Oct 6;16:3445-3446. doi: 10.2147/DDDT.S392088. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36238197 Free PMC article.
-
A Novel Ocular Delivery of Brinzolamide Based on Gellan Gum: In vitro and in vivo Evaluation [Retraction].Drug Des Devel Ther. 2022 Dec 2;16:4109-4110. doi: 10.2147/DDDT.S399707. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36483460 Free PMC article.
-
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction].Drug Des Devel Ther. 2022 Nov 18;16:4013-4014. doi: 10.2147/DDDT.S398020. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36425307 Free PMC article.
-
Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction].Drug Des Devel Ther. 2022 Nov 18;16:4019-4020. doi: 10.2147/DDDT.S398024. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36425305 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
